Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Invictus MD announces initial harvest for AB Labs. https://technical420.com/cannabis-article/invictus-mds-investment-ab-labs-blooming
Load the boat baby
Should never of went this low !!!
Loading zone !! $2+ 2018
Invictus MD Strategies Corp is undervalued, says Echelon Wealth
http://www.cantechletter.com/2017/07/invictus-md-strategies-corp-undervalued-says-echelon-wealth/
Invictus MD Strategies (TSXV:IMH) is a cannabis producer that should be on the radar of investors, says Echelon Wealth Partners analyst Russell Stanley.
In a research report to clients Wednesday, Stanley initiated coverage of Invictus MD Strategies with a “Speculative Buy” rating and a one-year price target of $2.00, implying a return of 82 per cent at the time of publication. The analyst says Invictus, which has interests in two Health Canada licensed facilities and has a third application in development, is particularly attracive right now due to a recent and sharp downturn in share price.
“We view Invictus as an underfollowed cannabis producer with significant fully-funded growth potential,” the analyst says. “Possible catalysts include expansion announcements, improved financial results, and forthcoming clarity on the regulatory environment for Canada’s cannabis recreational market. Our target price is based on our estimates for F2020, although given the Company’s January FYE, we view its F2020 as essentially equivalent to C2019. We attribute the recent share price weakness to the expiration of the hold period on the March 2017 financing, presenting a buying opportunity for investors.”
http://www.cantechletter.com/2017/07/invictus-md-strategies-corp-undervalued-says-echelon-wealth/
Invictus Poised to Have First-Mover Advantage in Canada’s Legal Cannabis Market
http://www.4-traders.com/INVICTUS-MD-STRATEGIES-CO-26786057/news/Invictus-MD-TSX-V-IMH-OTC-IVITF-Poised-to-Have-First-Mover-Advantage-in-Canada-rsquo-s-Legal-C-24711172/
Retail sales in Canada’s recreational marijuana market could climb to $6.0 billion by 2021, according to Deloitte Canadian, and Invictus MD Strategies Corp. (TSX.V: IMH) (OTC: IVITF) is strategically positioned to grow right alongside this burgeoning market and gain first-mover advantage as soon as Canada’s cannabis market is freed up by the necessary legislative regulations.
Founded in Vancouver, Canada, Invictus MD is a cannabis company that is dedicated to offering high-quality, regulated pharma-grade marijuana for both medical and recreational use using clean and organic production practices. The company represents a platform of licensed cannabis producers located throughout Canada who operate under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company’s growers are supported by more than 250 acres of production capacity and have total access to Invictus MD’s team of leading horticulturists, biochemists and project managers.
Since its inception, Invictus MD has had its developmental focus on a future time when the marijuana industry will be fully opened into a regulated consumer market. Boosted by legislative progress in Canada, the company has quickly established one of the strongest cultivation profiles in that country, with fully expandable facilities that allow its licensed producers to meet the growing demand for medical cannabis and, soon, for recreational marijuana, as well.
Invictus MD intends to constantly innovate its cultivation process and deploy long-term expansion plans to strengthen its production capacity. In carrying out its strategy for market domination, Invictus MD has completed various shrewd acquisitions that have resulted in huge ROIs (http://nnw.fm/hO3dH). In all thus far, the company has expended $1.1 million in acquisitions and has gained over $4.1 million in disposals.
Invictus MD stands out among very few Canadian cannabis companies that have declared dividends and is well-positioned to become a leader in the legal cannabis space – not just in Canada but globally.
For more information, visit the company’s website at http://www.Invictus-MD.com
For more information please visit https://www.NetworkNewsWire.com
http://www.4-traders.com/INVICTUS-MD-STRATEGIES-CO-26786057/news/Invictus-MD-TSX-V-IMH-OTC-IVITF-Poised-to-Have-First-Mover-Advantage-in-Canada-rsquo-s-Legal-C-24711172/
I'm about to load again gets any cheaper ...lol
Patience And
Perspective
$ivitf
I firmly be
I've the market in whole was shorted ...
Imho come august forward stocks will rise and gain new highs before march 2018 .,,,
Alberta sees new cannabis producers enter game amid volatility
http://www.calgarysun.com/2017/06/20/alberta-sees-new-cannabis-producers-enter-the-game-amid-volatility
Alberta's latest cannabis growers said Tuesday they remain bullish about the nascent industry despite a major sell-off of pot stocks that has sent share prices tumbling for months.
After submitting its application for a production license four years ago, Airdrie's Sundial Growers secured Health Canada's approval last week, becoming the third legal producer of medical marijuana in Alberta.
The facility west of Airdrie is relatively small for the industry, at 30,000 square feet, but the company plans to break ground in the coming weeks on a $120-million grow-op spanning 400,000 square feet in the central Alberta town of Olds.
Sundial, which remains privately held, has not faced any problems raising money through private equity deals to fund its expansion, despite indications of investor fatigue in public markets, said Stan Swiatek, the company's founder and chief operating officer.
Swiatek said there is a race underway across the cannabis industry to build production facilities big enough to capture a slice of the medical and recreational markets — and investors have been supporting the growth.
"You're forced to be large," he said, adding Sundial has no immediate plans to become publicly traded, but likely will be in the future.
Canadian cannabis stocks have taken a nosedive since hitting a peak in April, shortly before Ottawa tabled its bill to legalize pot, amid an industry-wide sell-off.
There are widespread concerns that cannabis companies are overvalued on the stock market, while analysts also suggest the arrival of several new producers in the past several months has sparked investor fatigue.
Aurora Cannabis, Alberta's first cannabis producer and one of the country's largest marijuana companies, closed at $2.15 each Tuesday afternoon, down by a third from its April peak and almost 10 per cent below the first day of trading in 2017.
Acreage Pharms, which owns a small production facility with potential to expand on 60 hectares of land west of Edmonton, was Alberta's second company to receive a license to grow by Health Canada late March.
A month later, Vancouver-based Invictus MD Strategies Corp. announced it was buying Acreage Pharms for shares and cash worth $42 million, based on its share price at the time.
Invictus, which owns stakes in a licensed grower in Ontario and a fertilizer supplier in B.C., has seen its share price fall by a third since the April peak along with the rest of the industry. Valued at nearly $53 million on the stock market, the company saw its shares close Tuesday at $1.39 each.
Trevor Dixon, the chief executive of Invictus and Acreage Pharms, said investors have been attracted by the company's growth plans and its debt-free balance sheet.
Invictus reported late May it had raised $25 million by issuing shares and would use the cash to fund its expansion plans.
"We have the cash to grow an awful lot," Dixon said.
Once cannabis companies secure licenses to grow medical cannabis, they must undergo additional scrutiny to get Health Canada's approval to sell it, a process that's underway at both Acreage Pharms and Sundial Growers.
http://www.calgarysun.com/2017/06/20/alberta-sees-new-cannabis-producers-enter-the-game-amid-volatility
Down ~50% since recent highs
This should turn around soon!
IMHO
I'd be adding more here today too if I could
Good luck everyone $ivitf
Don't tell me that !! Lol
Looks like u we're right :)
I agree
... Patience And
Perspective !
$ivitf
I think this stock is undervalued.
it should be trading around $4 right now.
Howdy! IVITF
what's the market cap of this stock?
Gltu , I already think it's to low !
This is a bloody screaming buy.
I will be adding more on Monday.
Invictus MD Announces Inclusion on Horizons Marijuana Life Sciences Index ETF
VANCOUVER, June 23, 2017 /PRNewswire/ - INVICTUS MD STRATEGIES CORP. ("Invictus MD" or the "Company") (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce its inclusion in the Horizon Medical Marijuana Life Sciences ETF (TSX:HMMJ) ("HMMJ ETF"), which is trading, and is the first ETF to offer direct exposure to North American-listed stocks that operate in the legal medical cannabis industry.
Horizon Medical Marijuana Life Sciences ETF is the first exchange-traded fund that offers investors direct exposure to North American-listed stocks that are involved with biopharmaceuticals, medical manufacturing, distribution, bio-products, and other businesses ancillary to the marijuana industry. Invictus MD joins the 19 other constituents. Only stocks that meet minimum asset and liquidity thresholds are qualified for inclusion in the index, and no single stock may exceed 10% of the weight of the Index when rebalanced.
"Invictus MD's inclusion to Horizon's Marijuana Life Sciences Index ETF represents an important achievement for our company and recognizes the enormous efforts and successes of our team," said Dan Kriznic, Executive Chairman. "Inclusion in the ETF will help broaden participation in Invictus MD's shares, and improve trading liquidity for our shareholders."
About Invictus MD Strategies Corp.
Invictus MD Strategies Corp. is focused on two main verticals within the burgeoning Canadian cannabis sector: Licensed Producers under the ACMPR, including its wholly owned subsidiary Acreage Pharms Ltd., as well as its investment in the fully licensed facility AB Laboratories Inc.; and Fertilizer and Nutrients through Future Harvest Development Ltd.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information, please visit www.invictus-md.com.
On Behalf of the Board,Dan KriznicExecutive Chairman
Larry HeinzlmeirVice President, Marketing & Communications604-537-8676
SOURCE Invictus MD Strategies
Nice news out !!!
Nice day today !!
Thinking we get a bigger buildout then they are saying ?
THIS IS READY FOR A NICE POP! WHOS READY FOR $5.00 BY YEAR END
YOU HEARD IT HERE FIRST
APPLES
and I just went into Sedar and looked at their annual--remember, they've done more than one deal this year--as of Jan. 31, their year end, they had 10,509,293 shares outstanding. I don't know what you are reading, but I'd burn it.
excboe, aren't you getting shares authorized mixed up with shares outstanding? Reuters says they have 38,063,656 out with 75% owned by insiders/institutions (by "institutions" I mean two hedge funds)
Name me a stock with 2 cultivation license and no. Debt and 35 m cash ....
Acreage pharma has a license
Dumped 25K of stock. When I bought after reviewing the investor deck it said that they had enough shares outstanding at 50 million for projections and now updated investor deck says they have 110 million. They are at least 1 year from getting sales license on Acreage Pharm. And 2 years from build out. This POS has market cap over 110 million and so why would I buy this when I can buy company that has sales license and build out ready to go. Total bait and switch. You are buying 10K square feet of production and a bunch of dirt. Does Bill Chaaban work for you guys?
Remember it's a Canada stock , more volume on that side ...
But chart looking. Great
with 6,690 volume, it looks like it is still undiscovered.
Slowly but surely
I'd be adding if I could
Canada's Cannabis Company. IVITF $ money bags
Sector ready to bounce ....
Invictus MD Strategies Chairman Dan Kriznic Podcast Interview
https://www.midasletter.com/podcast/invictus-md-strategies-chairman-dan-kriznic-podcast-interview/
Executive Chairman Dan Kriznic sat down recently and laid out the company’s goal of becoming one of the top licensed ACMPR cannabis producers in Canada.
James West: Dan, thanks for joining me today.
Dan Kriznic: Thanks for having me.
James West: Dan, why don’t we start with an overview: what’s the value proposition for investors in Invictus MD Strategies Corp?
Dan Kriznic: Yes. At this point, our main goal is to be one of the top licensed producers in Canada. We’ve since acquired over the last six months, two licensed producers, a third in Hamilton, Ontario, a company called A B Laboratories, and another one we just acquired two weeks ago, 100 percent of Acreage Farms, the second actual licensed producer out in Alberta.
James West: Okay. So you’re a consolidator of ACMPR licensees in Canada?
Dan Kriznic: At this point, consolidator wouldn’t be the right word. We’re looking at a footprint across the country, but not necessarily in every single province. So we’d like to kind of build out economics with the current ACMPRs that we have, but we’ll continue to look at other opportunities if they arise. But I would say at this juncture, we’re looking for definite expansion, because we’ve got 150 acres in Alberta; we’ve got, we’re just about to acquire another 100 acres in Hamilton, so we’ve got a very large land footprint to be able to build as many square feet as we require for the upcoming recreational market.
James West: Right. Okay, so are you – how many acres or square feet do you have under cultivation collectively right now?
Dan Kriznic: Currently we have 7,000 over in Alberta, with a 30,000 square foot expansion plan currently underway, and then we’ve got 16,000 square feet in Hamilton, Ontario. And with our expansion plan on the 100 acres within the next 12 months, we plan to put on another 42,000 square feet.
James West: How many ACMPR patients do you have?
Dan Kriznic: Right now we’re still in cultivation only, so AB Laboratories just received their license to cultivate on October 21st, and Acreage Farms just received their license to cultivate last month.
James West: Mm-hmm. Okay, so in that you’re targeting becoming one of the largest, so you’re setting your sights on basically the same positioning as Canopy, Aurora and Aphria, the biggest ones?
Dan Kriznic: Of course. So it’s still early days; right now we’re talking about patients, right? So by 2020, the estimate is going to be 150,000 kilos for the medicinal market, but 600,000 kilos on the rec market. So we’re gearing up to get enough square footage and buildout for the rec market that’s coming up, and that’s going to include various branding. We’ve hired our VP of Marketing and Communications; he used to be the Chief Marketing Officer of a large education company, very used to branding and bringing in students, but we’re looking at obviously bringing in clients.
So even though that we’re a bit behind in terms of a sales license and getting patients, we’ve already had significant demand for patients within our marketplace, and as we continue to work towards this July 2018 recreational market, we’ll be one of the top guys in terms of square footage at that point.
James West: So there aren’t a lot of growers in western Canada at this point?
Dan Kriznic: There are in British Columbia, but not in Alberta. So in Alberta there’s only Aurora and Acreage Farms, and we own 100 percent of Acreage Farms.
James West: And is the location of the provider of ACMPR-grown product important to the consumer, in your opinion?
Dan Kriznic: I think as we kind of move towards provincial regulations, so as we go into this rec market, we’re talking to Health Canada and the Federal government is talking about regulating it provincially. So I think to have a footprint in various provinces is pretty important.
James West: Okay. Is there any aspect of your approach to plant science that differentiates you from the other ACMPR growers?
Dan Kriznic: At this point right now, it’s about getting strain selection. Right now, there’s a lot of new growers coming online that actually don’t have a lot of access to starter material, but as we continue to look at the international market and work with Health Canada and get seeds from other areas, I think a big part of that is going to be, as I mentioned, strain. Number of strains, and the various different kind of strains, whether we’re going down the medicinal route or the recreational route, and whether it’s going to be high CBD for people with epilepsy or high THC for cancer patients or high THC for the rec market. I think strain selection is going to be a big player.
James West: Sure. So right now, do you source your genetics from other genetics providers licensed by Health Canada?
Dan Kriznic: Correct.
James West: Okay. So in your view, do you see that the ACMPR marketplace is becoming a little bit saturated in anticipation of this rec market, and do you think that there’s going to continue to be room for companies that are setting out to grow 150,000 kilograms per year, much longer?
Dan Kriznic: At this stage, there’s 43 licenses, so I don’t think it’s saturated at this point. We’re talking 720,000 kilos between the rec and the medicinal side. My conversion is about 10 percent, so you need about 7.2 million square feet to grow that, and that’s not currently out there.
Whether Health Canada is going to continue to provide licenses is to be determined; much more have come online in the recent months. But as we look at Health Canada and their ability to continue to regulate and manage these licensed producers, it’s going to become very difficult for them, right? If there’s going to be 100 in the next, say, year, that could be impossible. But if you look at the Colorado market that’s saturated, there’s over 450 cultivators out there, and it has depressed prices, etcetera, I don’t really see that happening in Canada just yet because I don’t see that Health Canada, with all their rigour in terms of inspection and going in to continuously monitor these licensed producers, I just can’t see them being able to monitor that many.
James West: Right. Okay. So then in terms of the rec market, how do you see yourself positioning Invictus relative to other companies? Is it going to be a sort of a western Canadian brand that will attract recreational users in western Canada? Or are you going to go the path of celebrity endorsement, or have you got far enough down the road to think about that yet?
Dan Kriznic: Yeah, definitely it’ll be about branding. Branding has to start now, regardless of the rec market coming down later; we want people to recognize our brand early on, so once it comes fully into recreational, they understand it. celebrity endorsements, I’m not a huge believer in; I haven’t seen it work. The US have tried it, a lot of the guys have been trying to endorse celebrities and get them to help sell product, but I just don’t see that as a key.
I think that, just like any other business, branding is going to be very important, and our pasts between myself and our VP of Marketing, when we built Canada’s largest education company, it was all about branding. So we’re just going to take what we did in the past and apply it to this industry.
James West: Okay. So your background is in the education industry?
Dan Kriznic: Correct.
James West: Could you maybe elaborate on your last successes?
Dan Kriznic: Yeah. So we built Canada’s largest for-profit education company in a period of four years, spanning 1,300 employees from Vancouver Island to Quebec City. 42 campuses with over 7,000 students, all private education, post-secondary. In terms of what we did since then, I basically left that to start Invictus; that was kind of the key goal. So exit on a number of divestitures within the space, and then started Invictus and incubated that as something I sort of wanted to cookie-cut in a different industry, but with somewhat similar attributes: highly regulated, very much driven by brand.
And in education, it’s about student acquisition, and cannabis right now is about patient acquisition. So taking a lot of the skill sets that we were able to be successful in the past, and applying it now.
James West: Okay. What other challenges do you see ahead for new entrants like Invictus into the ACMPR space who are, you know, there’s an increasing number of companies coming in under ACMPR, but really, they’re positioning for the recreational market, as, arguably, are the incumbent ACMPR growers. So for you, what challenges do you see that you’re going to have to overcome being a late starter?
Dan Kriznic: I would say the challenges, not necessarily that we have to overcome but the whole industry has to overcome, is quality. And what’s happening right now is you’re reading about various different pesticides that are going into the product, recalls that are happening…so when I look at our team and what we’re doing, we also own a fertilizer company. So we kind of control right from the nutrient side all the way to the end product, so in terms of what nutrients we use and what goes into the plants, it’s very much controlled.
So I think that quality and, let’s say, quality control is going to be a big challenge for all, and we’ve seen it in the marketplace.
In terms of us individually, from a challenge perspective, it’s going to be like any business. It’s going to be build a brand, make sure there’s enough capital to build expansion, build proper, you know, we’re not about buying buildings and then retrofitting; we’re about building from scratch, because it makes so much difference when you’re building from scratch. So, you know, I think that we’ll see over the next year or two, as we go into the rec side, that there’s going to be a few challenges and a few risks, but in general, it’s an industry that has been around for decades. It’s not something new.
People talk about ‘tech bubble’. This is not a tech bubble. This is, like I said, this has been a dark industry for years and now we’re bringing it to the light, and we’re able to capture tax revenues, etcetera off of it, and it’s something that society is accepting. So I think we’re going to embrace all the challenges that we might face.
James West: Okay. And finally, as an individual from the education industry, who do you have on your team that sort of you can point to and say, this is the guy who’s driving the bus in terms of plant science and genetics and everything?
Dan Kriznic: Yeah, so we hired a guy out of the US for our Chief Horticulture Officer, Phillip Haig. Phillip Haig has been, he very much understands the genome and understands cradle to grave from building facilities – he’s built a million square feet of licensed facilities in the US. He’s currently working on half a million square feet in New York, 125,000 square feet in Chicago, and his whole background has been plant science. He’s been on the team now for about six months, so he’s helping us build our facilities, he’s helping us source strains and seeds, he’s been featured on 60 Minutes, National Geographic…he’s very well known in the space.
So I would say that he’s been our kind of key guy within the team to be able to take that to the next level.
James West: Okay. That’s great. We’ll leave it there; I’ll come back to you in a quarter’s time and see how you’re doing. Thanks so much for your time today.
Dan Kriznic: Right on. Thanks for having me.
https://www.midasletter.com/podcast/invictus-md-strategies-chairman-dan-kriznic-podcast-interview/
Followers
|
103
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
7743
|
Created
|
02/08/17
|
Type
|
Free
|
Moderators |
The companies we seek to invest in demonstrate certain traits, which we believe are attractive to the creation of long-term shareholder value. Those traits include:
We work in partnership with management teams to increase shareholder value through business planning and process integration, developing and executing growth strategies, leveraging our experience and relationships, and structuring and deploying the proper capital to support long-term growth. Our prudent approach to both investing in and developing successful companies ensures successful execution of the business plan in both times of economic expansion and contraction.
Invictus MD’s primary objective is to identify, grow and build companies that are complementary to one another. We not only provide capital to meet these objectives but also years of management experience from a team that has been successful in all facets of business from start-ups to running large international organizations. The fundamental core of our operations is centered on the vast opportunities within fragmented industries.
We recognize the key to success is in our people. Our strong management team has built and managed successful operations with enterprise values over $500 million in various industries. We believe each of our team members bring a unique skill set that helps drive the growth of our portfolio companies.
The benefit that results when we work together with our portfolio companies is much greater than when our portfolio companies work alone. Our investment philosophy requires all investments to be synergistic in order to allow for effective and efficient growth plans. This creates economies of scale and builds competencies that are core to our operating activities.
We recognize the importance of seeking leading edge companies that operate in emerging industries in order to build our global community. Our extensive business network allows for us to identify and executive on these opportunities.
Our core focus is to identify and invest in companies operating in emerging markets. We recognize that through technological advancements the world is getting smaller and various opportunities exist to assist and enter into these new markets.
Our team works closely with the management of the portfolio companies on a daily basis to help support them in all areas of their business including operations, financial reporting, information technology, human resources and marketing.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |